Roche has decided to stop developing satralizumab for bone health in Duchenne muscular dystrophy, the company announced.

Researchers identified a molecular pathway that can limit muscle repair, a finding that may guide future muscular dystrophy treatments.

After following the Olympics, columnist Robin Stemple envisions a future with new treatments and even a cure for FSHD.

After years of focusing on her large family, and three sons with Duchenne MD, columnist Betty Vertin is eager to reconnect with friends.

Columnist Patrick Moeschen turns to classic writers and poets to express how he is choosing hope in life with limb-girdle muscular dystrophy.